These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route 89501-90-6, its application will become more common.
Some common heterocyclic compound, 89501-90-6, name is 1-Methyl-1H-pyrazole-3-sulfonyl chloride, molecular formula is C4H5ClN2O2S, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route. 89501-90-6
To a mixture of 4-(lH-pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H- pyrrolo[2,3-d]pyrimidine (prepared as described in WO 2007/070514 Example 65; 0.248 g, 0.785 mmol) in 1,4-dioxane (4 mL)was added 1.0 M of potassium tert-butoxide in tert-butyl alcohol (0.822 mL, 0.822 mmol). The reaction was stirred at RT for 10 min. To the resulting mixture was added benzyl 4-{3-fluoro-2-[(methylsulfonyl)oxy]propyl}piperazine-l- carboxylate (0.280 g, 0.748 mmol). The reaction was stirred at 95 C for 2 h, quenched with aqueous ammonium chloride, and extracted with EtOAc. The combined organic layers were washed with water, brine, dried and evaporated to dryness. The residue was purified on silica gel column, eluting with 0 to 80% EtOAc in hexanes, to provide the desired product and (+/-)- benzyl 4-(2-fluoro-l-{[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin- 4-yl)-lH-pyrazol-l-yl]methyl}ethyl)piperazine-l-carboxylate (128 mg, 28.8%). LCMS calculated for C3oH4iF 703Si(M+H)+: m/z = 594.3; Found: 594.3. A mixture of (+/-)-benzyl 4-{3-fluoro-2-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H- pyrrolo[2,3-d]pyrimidin-4-yl)-lH-pyrazol-l-yl]propyl}piperazine-l-carboxylate (0.064 g, 0.11 mmol) and (+/-)-benzyl 4-(2-fluoro-l-{[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H- pyrrolo[2,3-d]pyrimidin-4-yl)-lH-pyrazol-l-yl]methyl}ethyl)piperazine-l-carboxylate (0.064 g, 0.11 mmol) in 5 mL of methanol was hydrogenated in the presence of 5% Pd/C, under balloon pressure of hydrogen, for 2 h. After filtering off the catalyst, the filtrate was concentrated and used directly in next step. LCMS calculated for C22H35F 70Si(M+H)+: m/z = 460.3; Found: 460.4. To a mixture of (+/-)-4-{ l-[2-fluoro-l-(piperazin-l-ylmethyl)ethyl]-lH-pyrazol-4-yl}- 7- {[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine (0.050 g, 0.11 mmol) and (+/-)-4- [ 1 -(3 -fluoro-2-piperazin- 1 -ylpropyl)- 1 H-pyrazol-4-yl]-7- { [2- (trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine (0.050 g, 0.11 mmol) in acetonitrile (2 mL) was added triethylamine (0.0606 mL, 0.435 mmol) followed by 1-methyl- lH-pyrazole-3-sulfonyl chloride (0.0491 g, 0.272 mmol). The reaction was stirred at RT for 1 h and evaporated to dryness. LCMS calculated for C26H39F 903SSi(M+H)+: m/z = 604.3; Found: 604.4. The crude mixture from above was treated with 2 mL of TFA at RT for 1 h, evaporated to dryness. The residue was dissolved in 3 mL of methanol and treated with 100 muL ethylenediamine at RT for 1 h. The reaction mixture was purified on RP-HPLC (XBridge C-18 Column, eluting with a gradient of acetonitrile/water containing 0.1% TFA to give the desired products as TFA salts. First peak, with retention time 0.844 min at Waters SunFire HPLC column (CI 8, 2.1×50 mm, 5 muMu, injection volume 2 muL, flow rate 3 mL/min, eluting with a gradient from 2 to 80% of acetonitrile/water with 0.025% TFA, was found to be titled compound, LCMS calculated for C2oH25F 902S(M+H)+: m/z = 474.2; Found: 474.1. Second peak with retention time 0.961 min at the same analytical HPLC conditions was isomer (+/-)-4- ( 1 -(3 -fluoro-2-(4-( 1 -methyl- 1 H-pyrazol-3 -ylsulfonyl)piperazin- 1 -yl)propyl)- 1 H-pyrazol-4- yl)-7H-pyrrolo[2,3-d]pyrimidine, LCMS calculated for C2oH25F 902S(M+H)+: m/z = 474.2; Found: 474.1.
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route 89501-90-6, its application will become more common.